OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. Nasdaq: $OKYO

ID: 1380514994777960449

linkhttps://www.okyopharma.com/ calendar_today09-04-2021 13:36:51